Innovative solutions to
keep your project on course

Study Design and Conduct

Collection of relevant and high-quality Phase 1 clinical pharmacology study data requires both robust protocol design and experienced study oversight. Careful planning with the help of a clinical pharmacologist or pharmacokineticist is crucial to avoid missteps in your clinical studies.

Nuventra has extensive experience with the design, conduct, analysis, and interpretation of data from each type of Phase 1 clinical pharmacology study needed for an individual drug development program.

While we can conduct any Phase 1 study, our focus and expertise in clinical pharmacology is our differentiator. This is about much more than just conducting one study, it’s about an integrated approach to designing, conducting, analyzing, and interpreting Phase 1 studies within the context of your overall drug development program. As part of the study design phase, our senior consultants will conduct a review of your clinical pharmacology strategy to establish an understanding of existing data and how to maximize the impact of the next study on the overall plan.

Clinical Pharmacology Studies Supported:

Our Phase 1 Study Design and Conduct Services:

  • Clinical pharmacology strategy development/review
  • Study design and protocol development
  • Study startup activities
  • Data management (eCRF, randomization, database build, edit check, etc.)
  • Robust PK analysis and standalone PK Report
  • Biostatistics
  • Clinical study report (CSR)
  • Study management
  • Clinical monitoring
  • Medical monitoring
  • CDISC datasets
  • Documents that are eCTD-publishing ready
  • Post-study update, if necessary, to clinical pharmacology strategy

Explore Our Blog

Metabolites: Formation, Identification, and Impact on Drug Development

Although much of the drug development process focuses on characterizing the activity and safety profile of the drug substance (i.e.,…

Read More

Understanding the Value of a Gap Analysis in Drug Development

Today, the cost of developing a new drug is higher than ever, driven in large part by unproductive or unnecessary…

Read More
PK in Pregnant Women

Considerations for PK Studies in Pregnant Populations

Most pharmacokinetics (PK) clinical studies, and most clinical studies in general, exclude pregnant women in order to protect the safety…

Read More